PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 260 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,155 | -37.2% | 14,270 | 0.0% | 0.09% | -34.8% |
| Q2 2023 | $189,791 | +14.9% | 14,270 | 0.0% | 0.14% | +9.8% |
| Q1 2023 | $165,247 | +41.6% | 14,270 | 0.0% | 0.12% | +36.7% |
| Q4 2022 | $116,729 | +40.6% | 14,270 | 0.0% | 0.09% | +34.3% |
| Q3 2022 | $83,000 | -36.2% | 14,270 | 0.0% | 0.07% | -8.2% |
| Q1 2022 | $130,000 | -52.4% | 14,270 | +7.0% | 0.07% | -50.0% |
| Q4 2021 | $273,000 | -19.9% | 13,341 | 0.0% | 0.15% | -27.0% |
| Q3 2021 | $341,000 | -38.2% | 13,341 | -15.5% | 0.20% | -34.9% |
| Q2 2021 | $552,000 | -14.4% | 15,795 | -18.4% | 0.31% | -22.7% |
| Q1 2021 | $645,000 | -38.9% | 19,367 | -52.4% | 0.40% | +5.0% |
| Q4 2020 | $1,056,000 | – | 40,712 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |